Blues highlight medical, benefit policy changes

Procedures for which BSBS Michigan has changed a billing guideline or added a new payable group will appear under Updates to Payable Procedures. UPDATES TO PAYABLE PROCEDURES
88299 Effective March 1, 2012, genetic testing for Cytochrome P450 Polymorphisms is payable when used for patients undergoing treatment with clopidogrel (Plavix®) in order to identify those who are poor metabolizers of the drug, for Chrysler bargaining unit and non-bargaining unit enrollees.

SOURCE: Source
INDUSTRY NEWS TAGS: Blue Cross Blue Shield Michigan

Share This Post:

Search Billing News

Billing News By TAG

Billing News By DATE